Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada
Conclusion Results are relevant to both clinicians and decision-makers. We confirmed the safety of PVZ. Use of PVZ increased steadily for children with miscellaneous conditions and medical complexity. Medical and social factors pose a risk for severe RIH and RSVH with accompanying burden of illness. A vaccine that protects against RSV is urgently required.
Key Points
[...] Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents | Abstract | open access Full text
Source: American Journal of Perinatology - Category: Perinatology & Neonatology Authors: Mitchell, Ian Li, Abby Bjornson, Candice L. Lanctot, Krista L. Paes, Bosco A. Tags: Original Article Source Type: research
More News: Brain | Bronchopulmonary Dysplasia | Canada Health | Cardiology | Children | Cystic Fibrosis | Heart | Heart Disease | Neurology | Perinatology & Neonatology | Respiratory Medicine | Smokers | Study | Vaccines